John Spoors

Head of Commercial Medicines Policy Analysis • NHS England

John works in the Medicines Analysis Team (MAT) at NHS England and supports a number of commercial policy areas including horizon scanning, Advanced Therapy Medicinal Products (ATMPs) and managed access. John and his team work closely with commercial colleagues, the DHSC and NICE to ensure activity is based on a robust and analytical policy platform. John has degrees in politics, economics and natural sciences from the University of Manchester and Open University respectively. He has an MSc in Public Health from the London School of Hygiene and Tropical Medicine, and is currently undertaking a part-time PhD there,  looking at patient preferences in relation to ATMPs. Prior to joining NHS England in 2018, John directed and delivered global pricing and market access projects in a wide range of therapy areas across the drug development cycle

Also speaking

Mimoun Azzouz

Director of GTIMC • University of Sheffield

Rodolphe Clerval

CEO • Coave Therapeutics

Simon Hort

Group Manager, Adaptive Production Control, Fraunhofer IPT  • Fraunhofer IPT

Event Info


2022 Spotlight Roundtables

Take a look at the 2022 sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.